Cxcr4 expression in patients with high-risk locally advanced renal cell carcinoma can independently predict increased risk of disease progression and poor overall survival

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3313-3318

  Li , Xiong ^a   Huang, Ying ^b,c   Xia, Juan ^b   Chen, Ni ^b   Wei, Qiang ^d   Li, Xiang ^d   Zhang, Peng ^d   Shen, Peng Fei ^d   Wang, Jia ^d   Zeng, Hao ^d  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b Department of Pathology ^*  (China)

^c FUJIAN PROVINCIAL HOSPITAL   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

CXCR4; Free survival; Locally advanced RCC; Overall survival; Prognosis; Progression

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, CXCR4; SURVIVAL RATE; YOUNG ADULT;

EID: 84864496897     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akashi T, Koizumi K, Tsuneyama K, et al (2008). Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci, 99, 539-42.
2. Bui MH, Seligson D, Han KR, et al (2003). Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res, 9, 802-11.
3. Bui MH, Visapaa H, Seligson D, et al (2004). Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J Urol, 171, 2461-6.
4. Charbonneau C, Gupta K, Miller JD, et al (2008). Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev, 34, 193-205.
5. D'Alterio C, Consales C, Polimeno MN, et al (2010). Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets, 10, 772-81.
6. Frank I, Blute ML, Cheville JC, et al (2002). An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the sign score. J Urol, 168, 2395-400.
7. Fredriksson R, Lagerstrom MC, Lundin LG, et al (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis- paralogon groups- and fingerprints. Mol Pharmacol, 63, 1256-72.
8. 8. Furusato B, Mohamed A, Uhlén M, et al (2010). CXCR4 and cancer. Pathol Int, 60, 497-505.
9. He X, Wei Q, Zhang X, et al (2010). Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions. Pathol Res Pract, 206, 712-5.
10. Janzen NK, Kim HL, Figlin RA, et al (2003). Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin N Am, 30, 843-52.
11. Kattan MW, Reuter V, Motzer RJ, et al (2001). A postoperative prognostic nomogram for renal cell carcinoma. J Urol, 166, 63-7.
12. Kim J, Mori T, Chen SL (2006). Chemokine receptor cxcr4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg, 244, 113-20.
13. Kim J, Takeuchi H, Lam ST, et al (2005). Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol, 23, 2744-53.
14. Klatte T, Seligson DB, Leppert JT, et al (2008). The chemokinereceptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol, 179, 61-6.
15. Kunkle DA, Haas NB, Uzzo RG (2007). Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep, 8, 19-30.
16. Lam JS, Shvarts O, Leppert JT, et al (2005). Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol, 173, 1853-62.
17. Lazennec G, Richmond A (2010). Chemokines and chemokine receptors: New insights into cancer-related inflammation. Trends Mol Med, 16, 133-44.
18. Leibovich BC, Blute ML, Cheville JC, et al (2003). Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97, 1663-71.
19. Maréchal R, Demetter P, Nagy N, et al (2009). High expression of cxcr4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer, 100, 1444-51.
20. Müller A, Homey B, Soto H, et al (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-6.
21. Nagasawa T, Tachibana K, Kishimoto T (1998). A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: Their functions in development, hematopoiesis and HIV infection. Semin Immunol, 10, 179-85.
22. Nielsen TO, Hsu FD, O'Connell JX, et al (2003). Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol, 163, 1449-56.
23. Pan J, Mestas J, Burdick MD, et al (2006). Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer, 5, 56.
24. Staller P, Sulitkova J, Lisztwan J, et al (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature, 425, 307-11.
25. Struckmann K, Mertz K, Steu S, et al (2008) pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. J Pathol, 214, 464-71.
26. Sun X, Cheng G, Hao M, et al (2010). CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev, 29, 709-22.
27. Tachibana K, Hirota S, Iizasa H, et al (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature, 393, 591-4.
28. Wang L, Wang L, Yang B, et al (2009). Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis. Clin Exp Metastasis, 26, 1049-54.
29. Wehler TC, Graf C, Biesterfeld S, et al (2008). Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease. J Oncol, 2008, 626340.
30. Zhao FL, Guo W (2011). Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma. Mol Biol Rep, 38, 1039-45.
31. Zou YR, Kottmann AH, Kuroda M, et al (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393, 595-9.